Research Article
Ketamine Inhibits Lung Fluid Clearance through Reducing Alveolar Sodium Transport
Table 1
Clinical characteristics of patients.
| | Control () | Amiloride () | Ketamine () | Keta+am |
| Age (year) | | | | | Male (%) |
50
|
40
|
60
|
80
| PaO2 (mmHg) | | | | | VC (L) | | | | | FEV1.0 actual value (L) | | | | | FEV1.0 actual/predicted (%) | | | | | FVC actual value (L) | | | | | FVC actual/predicted (%) | | | | | FEV1.0/FVC (%) | | | | |
|
|
VC: vital capacity; FEV1.0: forced expiratory volume in 1.0 s; FVC: forced vital capacity. One-way ANOVA.
|